Search

everythinglearnresearchcommunity

for

Search:↓

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The document's conclusion cannot be provided because the document is not available or cannot be read.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Clascoterone is safe for the heart, even at high doses.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Optimized film improves finasteride skin absorption and treatment efficiency.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.